These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24470792)

  • 1. Drug release analysis and optimization for drug-eluting stents.
    Li H; Zhang Y; Zhu B; Wu J; Wang X
    ScientificWorldJournal; 2013; 2013():827839. PubMed ID: 24470792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design optimization of stent and its dilatation balloon using kriging surrogate model.
    Li H; Liu T; Wang M; Zhao D; Qiao A; Wang X; Gu J; Li Z; Zhu B
    Biomed Eng Online; 2017 Jan; 16(1):13. PubMed ID: 28086895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-objective optimization of coronary stent using Kriging surrogate model.
    Li H; Gu J; Wang M; Zhao D; Li Z; Qiao A; Zhu B
    Biomed Eng Online; 2016 Dec; 15(Suppl 2):148. PubMed ID: 28155700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Objective Optimizations for Microinjection Molding Process Parameters of Biodegradable Polymer Stent.
    Li H; Liu K; Zhao D; Wang M; Li Q; Hou J
    Materials (Basel); 2018 Nov; 11(11):. PubMed ID: 30463214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling intravascular delivery from drug-eluting stents with biodurable coating: investigation of anisotropic vascular drug diffusivity and arterial drug distribution.
    Zhu X; Pack DW; Braatz RD
    Comput Methods Biomech Biomed Engin; 2014; 17(3):187-98. PubMed ID: 22512464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of Drug Delivery by Drug-Eluting Stents.
    Bozsak F; Gonzalez-Rodriguez D; Sternberger Z; Belitz P; Bewley T; Chomaz JM; Barakat AI
    PLoS One; 2015; 10(6):e0130182. PubMed ID: 26083626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving smooth muscle cell exposure to drugs from drug-eluting stents at early time points: a variable compression approach.
    O'Connell BM; Cunnane EM; Denny WJ; Carroll GT; Walsh MT
    Biomech Model Mechanobiol; 2014 Aug; 13(4):771-81. PubMed ID: 24101254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design optimization of coronary stent based on finite element models.
    Li H; Qiu T; Zhu B; Wu J; Wang X
    ScientificWorldJournal; 2013; 2013():630243. PubMed ID: 24222743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of different tissue-simulating hydrogel compartments on in vitro release and distribution from drug-eluting stents.
    Semmling B; Nagel S; Sternberg K; Weitschies W; Seidlitz A
    Eur J Pharm Biopharm; 2014 Aug; 87(3):570-8. PubMed ID: 24801065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug eluting stents based on Poly(ethylene carbonate): optimization of the stent coating process.
    Bege N; Steinmüller SO; Kalinowski M; Reul R; Klaus S; Petersen H; Curdy C; Janek J; Kissel T
    Eur J Pharm Biopharm; 2012 Apr; 80(3):562-70. PubMed ID: 22209978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Numerical modeling of coronary drug eluting stents.
    Mongrain R; Leask R; Brunette J; Faik I; Bulman-Feleming N; Nguyen T
    Stud Health Technol Inform; 2005; 113():443-58. PubMed ID: 15923752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mathematical model for predicting drug release from a biodurable drug-eluting stent coating.
    Hossainy S; Prabhu S
    J Biomed Mater Res A; 2008 Nov; 87(2):487-93. PubMed ID: 18186043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A theoretical model to characterize the drug release behavior of drug-eluting stents with durable polymer matrix coating.
    Zhao HQ; Jayasinghe D; Hossainy S; Schwartz LB
    J Biomed Mater Res A; 2012 Jan; 100(1):120-4. PubMed ID: 21997889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geometry parameterization and multidisciplinary constrained optimization of coronary stents.
    Pant S; Bressloff NW; Limbert G
    Biomech Model Mechanobiol; 2012 Jan; 11(1-2):61-82. PubMed ID: 21373889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of drug release and distribution from drug-eluting stents with a vessel-simulating flow-through cell.
    Seidlitz A; Nagel S; Semmling B; Grabow N; Martin H; Senz V; Harder C; Sternberg K; Schmitz KP; Kroemer HK; Weitschies W
    Eur J Pharm Biopharm; 2011 May; 78(1):36-48. PubMed ID: 21182943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of quality by design (QbD) approach to ultrasonic atomization spray coating of drug-eluting stents.
    McDermott M; Chatterjee S; Hu X; Ash-Shakoor A; Avery R; Belyaeva A; Cruz C; Hughes M; Leadbetter J; Merkle C; Moot T; Parvinian S; Patwardhan D; Saylor D; Tang N; Zhang T
    AAPS PharmSciTech; 2015 Aug; 16(4):811-23. PubMed ID: 25563817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical modeling of drug dynamics induced by eluting stents in the coronary multi-layered curved domain.
    d'Errico M; Sammarco P; Vairo G
    Math Biosci; 2015 Sep; 267():79-96. PubMed ID: 26162517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Numerical analysis of paclitaxel-eluting coronary stents: Mechanics and drug release properties.
    Gagliardi M
    Med Eng Phys; 2020 Aug; 82():78-85. PubMed ID: 32709268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the suitability of a fluidized bed process for the coating of drug-eluting stents.
    Wentzlaff M; Senz V; Seidlitz A
    Eur J Pharm Biopharm; 2019 Jun; 139():85-92. PubMed ID: 30878518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Objective Optimizations of Biodegradable Polymer Stent Structure and Stent Microinjection Molding Process.
    Li H; Wang X; Wei Y; Liu T; Gu J; Li Z; Wang M; Zhao D; Qiao A; Liu Y
    Polymers (Basel); 2017 Jan; 9(1):. PubMed ID: 30970706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.